An interleukin 5 mutant distinguishes between two functional responses in human eosinophils

Journal of Experimental Medicine

Volumn 186, Issue 1, 1997, Pages 121-129

  McKinnon, Murray ^a   Page, Kevin ^a   Uings, Iain J ^a   Banks, Martyn ^a   Fattah, Dilniya ^a   Proudfoot, Amanda E I ^b   Graber, Pierre ^b   Arod, Christian ^b   Fish, Richard ^b   Wells, Timothy N C ^b   Solari, Roberto ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5; MUTANT PROTEIN;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS;

CELLS, CULTURED; EOSINOPHILS; HUMANS; INTERLEUKIN-5; MUTATION; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5; SIGNAL TRANSDUCTION;

EID: 0030789070     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.1.121     Document Type: Article

References (41)

1. Bohjanen, P.R., M. Okajima, and R.J. Hodes. 1990. Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T-cell gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc. Natl. Acad. Sci. USA. 87:5283-5287.
2. Plaut, M., J.H. Pierce, C.J. Watson, J. Hanley-Hyde, R.P. Nordan, and W.E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of Fc∈RI or to calcium ionophores. Nature (Lond.). 339:64-67.
3. Dubucquoi, S., P. Desreumaux, A. Janin, O. Klein, M. Goldman, J. Tavernier, A. Capron, and M. Capron. 1994. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179:703-708.
4. Clutterbuck, E.J., E.M. Hirst, and C.J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood. 73: 1504-1512.
5. Walsh, G.M., A. Hartnell, A.J. Wardlaw, K. Kurihara, C.J. Sanderson, and A.B. Kay. 1990. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology. 71:258-265.
6. Fujisawa, T., R. Abu-Ghazaleh, H. Kita, C.J. Sanderson, and G.J. Gleich. 1990. Regulatory effect of cytokines on eosinophil degranulation. J. Immunol. 144:642-646.
7. Wang, J.M., A. Rambaldi, A. Biondi, Z.G. Chen, C.J. Sanderson, and A. Mantovani. 1989. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19:701-705.
8. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, K. Takatsu, and T. Suda. 1988. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167: 1737-1742.
9. Sanderson, C.J. 1992. Interleukin-5, eosinophils, and disease. Blood. 79:3101-3109.
10. Kroegel, C., J.C. Virchow, Jr., W. Luttmann, C. Walker, and J.A. Warner. 1994. Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I). Eur. Respir. J. 7: 519-543.
11. Kroegel, C., J.A. Warner, J.C. Virchow, Jr., and H. Matthys. 1994. Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part II). Eur. Respir. J. 7:743-760.
12. Kung, T.T., D.M. Stelts, J.A. Zurcher, G.K. Adams III, R.W. Egan, W. Kreutner, A.S. Watnick, H. Jones, and R.W. Chapman. 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. J. Respir. Cell Mol. Biol. 13:360-365.
13. Blyth, D.I., M.S. Pedrick, T.J. Savage, E.M. Hessel, and D. Fattah. 1996. Lung Inflammation and Epithelial changes in a murine model of atopic asthma. Am. J. Respir. Cell. Mol. Biol. 14:425-438.
14. Van Oosterhout, A.J., A.R. Ladenius, H.F. Savelkoul, I. Van Ark, K.C. Delsman, and F.P. Nijkamp. 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147:548-552.
15. Akutsu, I., T. Kojima, A. Kariyone, T. Fukuda, S. Makino, and K. Takatsu. 1995. Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways. Immunol. Lett. 45: 109-116.
16. Mauser, P.J., A.M. Pitman, X. Fernandez, S.K. Foran, G.K. Adams III, W. Kreutner, R.W. Egan, and R.W. Chapman. 1995. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J. Respir. Crit. Care Med. 152:467-472.
17. Tavernier, J., R. Devos, S. Cornelis, T. Tuypens, J. Van der Heyden, W. Fiers, and G. Plaetinck. 1991. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF. Cell. 66:1175-1184.
18. Kitamura, T., N. Sato, K. Arai, and A. Miyajima. 1991. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors. Cell. 66:1165-1174.
19. Hayashida, K., T. Kitamura, D.M. Gorman, K. Arai, T. Yokota, and A. Miyajima. 1990. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc. Natl. Acad. Sci. USA. 87:9655-9659.
20. Murata, Y., S. Takaki, M. Migita, Y. Kikuchi, A. Tominaga, and K. Takatsu. 1992. Molecular cloning and expression of the human interleukin 5 receptor. J. Exp. Med. 175:341-351.
21. Takaki, S., H. Kanazawa, M. Shiiba, and K. Takatsu. 1994. A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor α-chain and its function in IL-5-mediated growth signal transduction. Mol. Cell Biol. 14:7404-7413.
22. Cornelis, S., I. Fache, J. Van der Heyden, Y. Guisez, J. Tavernier, R. Devos, W. Fiers, and G. Plaetnick. 1995. Characterization of critical residues in the cytoplasmic domain of the human interleukin-5 receptor α chain required for growth signal transduction. Eur. J. Immunol. 25:1857-1864.
23. Sakamaki, K., I. Miyajima, T. Kitamura, and A. Miyajima. 1992. Critical cytoplasmic domains of the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO (Em. Mol. Biol. Organ.) J. 11:3541-3549.
24. Sato, N., K. Sakamaki, N. Terada, K. Arai, and A. Miyajima. 1993. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common β subunit responsible for different signaling. EMBO (Eur. Mol. Biol. Organ.) J. 12:4181-4189.
25. 2+ independent and accompanied by induction of tyrosine kinase activity. J. Leukoc. Biol. 53:347-353.
26. Kinashi, T., N. Harada, E. Severinson, T. Tanabe, P. Sideras, M. Konishi, C. Azuma, A. Tominaga, S. Bergstedt-Lindqvist, M. Takahashi et al. 1986. Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature (Lond.). 324:70-73.
27. Milburn, M.V., A.M. Hassell, M.H. Lambert, S.R. Jordan, A.E. Proudfoot, P. Graber, and T.N. Wells. 1993. A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5. Nature (Lond.). 363:172-176.
28. Graber, P., A.E. Proudfoot, F. Talabot, A. Bernard, M. McKinnon, M. Banks, D. Fattah, R. Solari, M.C. Peitsch, and T.N. Wells. 1995. Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation. J. Biol. Chem. 270:15762-15769.
29. Tavernier, J., T. Tuypens, A. Verhee, G. Plaetinck, R. Devos, J. Van der Heyden, Y. Guisez, and C. Oefner. 1995. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. Proc. Natl. Acad. Sci. USA. 92:5194-5198.
30. Proudfoot, A.E., D. Fattah, E.H. Kawashima, A. Bernard, and P.T. Wingfield. 1990. Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli. Biochem. J. 270:357-361.
31. Banks, M., P. Graber, A.E. Proudfoot, C.Y. Arod, B. Allet, A.R. Bernard, E. Sebille, M. McKinnon, T.N. Wells, and R. Solari. 1995. Soluble interleukin-5 receptor α-chain binding assays: use for screening and analysis of interleukin-5 mutants. Anal. Biochem. 230:321-328.
32. Fattah, D., K.R. Page, S. Bezbaruah, R. Preist, C.M. Horgan, and R. Solari. 1996. A rapid activation assay for human eosinophils based on adhesion to immobilized ICAM-1, VCAM-1 and IgG. Cytokine. 8:248-259.
33. Schumacher, J.H., A. O'Garra, B. Shrader, A. van Kimmenade, M.W. Bond, T.R. Mosman, and R.L. Coffman. 1988. The characterisation of four monoclonal antibodies specific for mouse interleukin (IL-)-5 and development of mouse and human enzyme-linked immunosorbent. J Immunol. 141:1576-1581.
34. Yamaguchi, Y., T. Suda, S. Ohta, K. Tominaga, Y. Miura, and T. Kasahara. 1991. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood. 78:2542-2547.
35. Her, E., J. Frazer, K.F. Austen, and W.F. Owen, Jr. 1991. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J. Clin. Invest. 88:1982-1987.
36. Takanaski, S., R. Nonaka, Z. Xing, P. O'Byrne, J. Dolovich, and M. Jordana. 1994. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med. 180:711-715.
37. Barry, S.C., C.J. Bagley, J. Phillips, M. Dottore, B. Cambareri, P. Moretti, R. D'Andrea, G.J. Goodall, M.F. Shannon, M.A. Vadas, and A.F. Lopez. 1994. Two contiguous residues in human interleukin-3, Asp21 and Glu22, selectively interact with the α- and β-chains of its receptor and participate in function. J. Biol. Chem. 269:8488-8492.
38. Lopez, A.F., M.F. Shannon, T. Hercus, N.A. Nicola, B. Cambareri, M. Dottore, M.J. Layton, L. Eglinton, and M.A. Vadas. 1992. Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding. EMBO (Eur. Mol. Biol. Organ.) J. 11:909-916.
39. Shanafelt, A.B., and R.A. Kastelein. 1992. High affinity ligand binding is not essential for granulocyte-macrophage colony-stimulating factor receptor activation. J. Biol. Chem. 267:25466-25472.
40. Hercus, T.R., C.J. Bagley, B. Cambareri, M. Dottore, J.M. Woodcock, M.A. Vadas, M.F. Shannon, and A.F. Lopez. 1994. Specific human granulocyte-macrophage colony-stimulating factor antagonists. Prof. Natl. Acad. Sci. USA. 91:5838-5842.
41. Mire-Sluis, A., L.A. Page, M. Wadhwa, and R. Thorpe. 1995. Evidence for a signaling role for the a chains of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors: divergent signaling pathways between GM-CSF/IL-3 and IL-5. Blood. 86:2679-2688.